

Learn about Rezdiffra drug interactions including statins, Gemfibrozil, and Cyclosporine. Know what to avoid and what to tell your doctor before starting.
If you're taking Rezdiffra (Resmetirom) for NASH/MASH, it's important to understand how it interacts with other medications. Some drug interactions can change how well Rezdiffra works, increase the risk of side effects, or require dose adjustments.
This guide covers the major and moderate drug interactions for Rezdiffra, plus supplements, over-the-counter products, and food considerations. Bring this information to your next doctor's appointment — or better yet, bring a complete list of everything you take.
Drug interactions happen when one medication affects how another is absorbed, processed, or eliminated by your body. With Rezdiffra, interactions mainly involve:
These interactions are significant and may require avoiding the combination entirely or making important dose changes:
Gemfibrozil is a fibrate used to lower triglycerides and cholesterol. It is a strong CYP2C8 inhibitor, meaning it can significantly increase Rezdiffra levels in your body. Using Gemfibrozil with Rezdiffra is not recommended. If you need triglyceride-lowering therapy, your doctor may suggest an alternative like Fenofibrate, which does not have the same interaction.
Cyclosporine is an immunosuppressant used after organ transplant and for certain autoimmune conditions. It inhibits OATP1B1 and OATP1B3 transporters, which can increase Rezdiffra exposure. If you must take both, your doctor should reduce your Rezdiffra dose to 60 mg daily.
Rezdiffra increases blood levels of several commonly prescribed statins. This raises the risk of myopathy (muscle pain and weakness) and, in rare cases, rhabdomyolysis (a serious condition where muscle tissue breaks down). When taking Rezdiffra, the following statin dose limits apply:
If you're currently taking a statin at a higher dose, your doctor will need to adjust it before starting Rezdiffra. Do not change your statin dose on your own — always work with your doctor.
Report any muscle pain, tenderness, weakness, or dark-colored urine to your doctor immediately, as these could be signs of statin-related muscle damage.
Clopidogrel is a blood thinner used to prevent heart attacks and strokes. It is a moderate CYP2C8 inhibitor. If you take Clopidogrel with Rezdiffra, your doctor may need to reduce your Rezdiffra dose and monitor you more closely for side effects.
Medications that are processed by the CYP2C8 enzyme may be affected when taken alongside Rezdiffra. Your doctor should monitor you more frequently for adverse reactions if you're taking other CYP2C8 substrates. Examples include certain diabetes medications like Repaglinide and Rosiglitazone.
While Rezdiffra doesn't have a long list of supplement interactions, it's still important to tell your doctor about everything you take, including:
The good news: Rezdiffra has no significant food interactions. You can take it with or without food, and there are no specific foods you need to avoid.
That said, general dietary advice for NASH/MASH patients still applies:
Before starting Rezdiffra, make sure your doctor has a complete picture of what you're taking. Here's a checklist:
If you're seeing multiple specialists (which is common for patients with NASH/MASH, diabetes, and heart disease), make sure each doctor knows about your Rezdiffra prescription. A pharmacist can also help review your full medication list for potential interactions.
Rezdiffra's drug interactions are manageable, but they require attention — especially if you're taking statins or other liver-metabolized medications. The most important thing you can do is be upfront with your healthcare team about everything you take.
For more on what to expect when taking Rezdiffra, see our guides on side effects and dosage information. When you're ready to fill your prescription, use Medfinder to check pharmacy availability near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.